Determinants of uraemic toxin removal
نویسندگان
چکیده
منابع مشابه
The use of SDS–PAGE scanning of spent dialysate to assess uraemic toxin removal by dialysis
BACKGROUND Uraemic toxins in the 8 to 60 kDa molecular weight range have been attracting increasing attention in dialysis therapy. However, there are no available standardized methods to evaluate their removal. Using new filtering membranes, we evaluated SDS-PAGE of spent dialysate to assess cut-off ranges and removal capacities into dialysate, while also measuring classical markers of dialyser...
متن کاملProtein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration.
BACKGROUND The accumulation of larger and protein-bound toxins is involved in the uraemic syndrome but their elimination by dialysis therapy remains difficult. In the present study, the impact of the albumin permeability of recently introduced advanced high-flux dialysis membranes on the removal of such substances was tested in haemodialysis and online post-dilution haemodiafiltration. METHOD...
متن کاملChapter 13: Cyanobacterial toxin removal recreational waters
Although federal drinking water regulations determine the quality of potable water, many specifics influence how each utility chooses to treatment water. Some of the specifics include source water quality, storage capacity, existing unit process, and space. An overview of the US recreational and drinking water regulations were discussed in context of cyanobacterial toxin removal and inactivatio...
متن کاملComa caused by Shigella toxin-producing Escherichia coli in the absence of haemorrhagic uraemic syndrome (HUS)
Shigella toxin-producing Escherichia coli (STEC) is well known for its complications such as haemolytic uraemic syndrome (HUS), but neurological symptoms have also been reported. While most cases of infection with STEC occur with concurrent HUS, we describe a patient with severe neurological symptoms in the absence of HUS. LEARNING POINTS • Shigella toxin producing Escherichia coli (STEC) are b...
متن کاملA mouse model of non-Shiga toxin-associated haemolytic uraemic syndrome.
Impaired control of the complement system activation due to mutations in complement factor H (CFH) has been described in two apparently unrelated human diseases, membranoproliferative glomerulonephitis type II (MPGN2) and non-Shiga toxin-associated haemolytic uraemic syndrome (non-Stx-HUS). Mouse models of these diseases have been developed by Pickering et al., by knocking-out Cfh gene (MPGN2) ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nephrology Dialysis Transplantation
سال: 2002
ISSN: 0931-0509,1460-2385
DOI: 10.1093/ndt/17.suppl_3.30